Meda to buy drugs maker Rottapharm for $3.08 billion

The Swedish pharma’s takeover of Italian peer Rottapharm comes just three months after Meda fought off a multibillion-dollar bid from Mylan
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.